JH-RE-06 is primarily used in research settings for its potential modulatory effects on cellular signaling pathways associated with tissue regeneration and inflammation. It has shown promise in preclinical studies for promoting nerve cell repair and enhancing recovery in models of neurodegenerative conditions. Due to its ability to cross the blood-brain barrier, it is being investigated for neuroprotective therapies. Additionally, JH-RE-06 exhibits activity in regulating oxidative stress responses, making it a candidate for studies on aging and mitochondrial dysfunction. Its application remains experimental and is not approved for clinical use.